Freedom Solo®与Trifecta®生物瓣膜倾向评分匹配后的临床与血流动力学评估
该纵向队列研究纳入单中心2009-16年连续接受主动脉瓣置换的患者,比较无支架Freedom Solo®(FS)与有支架Trifecta®(TF)生物瓣膜,经倾向评分匹配(21个协变量)后得到329对匹配样本;两组生存率与结构性瓣膜衰败联合感染性心内膜炎的累积风险无显著差异,TF血流动力学更优但左室质量退化无差异。
要点
- 匹配后两组生存率无显著差异(HR=1.04,95%CI 0.69-1.56)。
- 结构性瓣膜衰败联合感染性心内膜炎累积风险无显著差异(SHR=0.54,95%CI 0.21-1.39)。
- TF血流动力学更优,但左室质量退化无差异;TF机械通气延长率更高,FS血小板减少率更高。
核心结论
- TF较FS血流动力学更优,但未转化为进一步逆重构;两种生物瓣膜术后结局与生存率相当,与经典生物瓣膜模型比较需长期随访。
研究设计与样本
- 单中心纵向队列研究,纳入2009-16年连续接受主动脉瓣置换并植入FS或TF生物瓣膜的患者,查询本地数据库与国家记录,经倾向评分匹配(21个协变量)后分析。
- FS总样本397例,TF总样本525例,中位随访时间分别为4.0(2.2-6.0)年与2.4(1.4-3.7)年,匹配后得到329对样本。
主要发现
- 匹配组生存率无差异(HR=1.04,95%CI 0.69-1.56)。
- 结构性瓣膜衰败与感染性心内膜炎联合结局累积风险无差异(SHR=0.54,95%CI 0.21-1.39)。
- TF血流动力学更优,但左室质量退化无差异。
- TF组机械通气延长率更高,FS组血小板减少率更高。
局限性
- 原文结论指出,与经典生物瓣膜模型比较需长期随访。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: The goal of this study was to compare the stentless Freedom Solo® (FS) and the stented Trifecta® (TF) aortic bioprostheses with regard to haemodynamic profile, left ventricular mass regression and early and late postoperative outcomes and survival. METHODS: A longitudinal cohort study of consecutive patients undergoing aortic valve replacement (2009-16) with either the FS or TF at 1 centre was performed. Local databases and national records were queried. Prosthesis haemodynamics and left ventricular dimensions were obtained from postoperative echocardiograms. After propensity score matching (21 covariates), the Kaplan-Meier and competing risk analyses were performed for survival and the combined outcome of structural valve deterioration and endocarditis, respectively. Haemodynamics and mass regression were assessed by a mixed-effects model including propensity score as a covariate. RESULTS: From a total sample of 397 patients with the FS and 525 TF bioprostheses with a median follow-up time of 4.0 (2.2-6.0) and 2.4 (1.4-3.7) years, respectively, a matched sample of 329 pairs was obtained. Matched groups showed no differences in survival (hazard ratio = 1.04, 95% confidence interval = 0.69-1.56) or cumulative hazards of combined outcome (subdistribution hazard ratio = 0.54, 95% confidence interval = 0.21-1.39). Although the TF showed an improved haemodynamic profile, no difference was found in mass regression. Patients with TF bioprostheses had higher rates of prolonged mechanical ventilation, whereas patients with the FS bioprosthesis showed higher rates of thrombocytopenia. CONCLUSIONS: The TF showed an improved haemodynamic profile compared to the FS, but this did not translate into further reverse remodelling. Postoperative outcomes and survival rates were comparable for both bioprostheses. Long-term follow-up is needed for comparisons with classical bioprosthesis models.
引用
- Cerqueira RJ, Raimundo R, Moreira S, et al. Freedom Solo® versus Trifecta® bioprostheses: clinical and haemodynamic evaluation after propensity score matching. Eur J Cardiothorac Surg. 2018. PMID: 29351596. doi:10.1093/ejcts/ezx472
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。